Literature DB >> 25286967

New diagnosis of chronic pancreatitis: risk of missing an underlying pancreatic cancer.

Satish Munigala1, Fasiha Kanwal1, Hong Xian2, Banke Agarwal1.   

Abstract

OBJECTIVES: Patients with pancreatic cancer (PaCa) sometimes present with symptoms suggestive of chronic pancreatitis (CP). We evaluated the prevalence of undiagnosed PaCa in patients with new CP diagnosis.
METHODS: This is a retrospective study with data from Veterans Health Administration national medical care data sets from fiscal year 1998-2007. A 3-year washout period was used to identify patients with preexisting PaCa and preexisting CP diagnosis.
RESULTS: Among 471,992 veterans included, 917 (0.19%) had PaCa, 2,557 (0.54%) had a preexisting CP, and 2,175 (0.46%) had a new diagnosis of CP. PaCa was diagnosed ≤2 years following CP diagnosis in 44 patients, comprising 4.80% of patients with PaCa. Following a new diagnosis of CP, the risk of PaCa diagnosis was most marked in the first year (incidence 18.04 per 1,000 person-years (py), relative risk (RR) 63.43) and became similar to risk in patients with preexisting CP in the third year. The first-year incidence of PaCa was 7.33/1,000 py in the fifth decade and reached 36.91/1,000 py after seventh decade of life. Time to PaCa diagnosis following a CP diagnosis was ≤60 days in 14 patients, 3-12 months in 25 patients, and 13-24 months in 5 patients.
CONCLUSIONS: Approximately 5% of patients with PaCa are initially misdiagnosed as CP, and in two-thirds of these patients the cancer diagnosis is delayed by >2 months. PaCa should reliably be excluded before making a new CP diagnosis in patients who are >40 years old, especially in those without heavy smoking or alcohol history.

Entities:  

Mesh:

Year:  2014        PMID: 25286967     DOI: 10.1038/ajg.2014.318

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  10 in total

1.  Pancreatic cancer in patients with recently diagnosed chronic pancreatitis.

Authors:  Bai-Rong Li; Gao-Ping Mao; Liang-Hao Hu; Zhao-Shen Li
Journal:  Am J Gastroenterol       Date:  2015-05       Impact factor: 10.864

2.  High Expression of Cell Division Cycle 42 Promotes Pancreatic Cancer Growth and Predicts Poor Outcome of Pancreatic Cancer Patients.

Authors:  Dejun Yang; Yu Zhang; Yajun Cheng; Liang Hong; Changming Wang; Ziran Wei; Qingping Cai; Ronglin Yan
Journal:  Dig Dis Sci       Date:  2017-02-08       Impact factor: 3.199

Review 3.  Chronic Pancreatitis and Pancreatic Cancer Risk: A Systematic Review and Meta-analysis.

Authors:  Jakob Kirkegård; Frank Viborg Mortensen; Deirdre Cronin-Fenton
Journal:  Am J Gastroenterol       Date:  2017-08-01       Impact factor: 10.864

4.  Identification and Validation of a Diagnostic and Prognostic Multi-Gene Biomarker Panel for Pancreatic Ductal Adenocarcinoma.

Authors:  Hagen Klett; Hannah Fuellgraf; Ella Levit-Zerdoun; Saskia Hussung; Silke Kowar; Simon Küsters; Peter Bronsert; Martin Werner; Uwe Wittel; Ralph Fritsch; Hauke Busch; Melanie Boerries
Journal:  Front Genet       Date:  2018-04-05       Impact factor: 4.599

5.  Prognostic Implications of Intratumoral and Peritumoral Infiltrating Lymphocytes in Pancreatic Ductal Adenocarcinoma.

Authors:  Jung-Soo Pyo; Byoung Kwan Son; Hyo Young Lee; Il Hwan Oh; Kwang Hyun Chung
Journal:  Curr Oncol       Date:  2021-11-01       Impact factor: 3.677

6.  Clinical significance of pancreatic calcifications: a 15-year single-center observational study.

Authors:  Wei Wang; Li Chai; Naiyi Zhu; Qingrou Wang; Yiran Zhou; Weimin Chai
Journal:  Eur J Med Res       Date:  2022-06-25       Impact factor: 4.981

7.  Differentiation of pancreatic carcinoma and mass-forming focal pancreatitis: qualitative and quantitative assessment by dynamic contrast-enhanced MRI combined with diffusion-weighted imaging.

Authors:  Ting-Ting Zhang; Li Wang; Huan-Huan Liu; Cai-Yuan Zhang; Xiao-Ming Li; Jian-Ping Lu; Deng-Bin Wang
Journal:  Oncotarget       Date:  2017-01-03

8.  Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells.

Authors:  Hai-Bo Xing; Meng-Ting Tong; Jing Wang; Hong Hu; Chong-Ya Zhai; Chang-Xin Huang; Da Li
Journal:  Biomed Res Int       Date:  2018-03-06       Impact factor: 3.246

Review 9.  Pancreatoscopy: An update.

Authors:  Luca De Luca; Alessandro Repici; Adea Koçollari; Francesco Auriemma; Mario Bianchetti; Benedetto Mangiavillano
Journal:  World J Gastrointest Endosc       Date:  2019-01-16

10.  Identification of Individuals at Increased Risk for Pancreatic Cancer in a Community-Based Cohort of Patients With Suspected Chronic Pancreatitis.

Authors:  Christie Y Jeon; Qiaoling Chen; Wei Yu; Elizabeth Y Dong; Joanie Chung; Stephen J Pandol; Dhiraj Yadav; Darwin L Conwell; Bechien U Wu
Journal:  Clin Transl Gastroenterol       Date:  2020-04       Impact factor: 4.396

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.